Piper Sandler Maintains Overweight on Biomea Fusion, Raises Price Target to $45
Portfolio Pulse from richadhand@benzinga.com
Piper Sandler analyst Joseph Catanzaro maintains an Overweight rating on Biomea Fusion (NASDAQ:BMEA) and raises the price target from $40 to $45.
June 26, 2023 | 2:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler analyst maintains Overweight rating on Biomea Fusion (NASDAQ:BMEA) and raises price target from $40 to $45.
The news of Piper Sandler maintaining an Overweight rating on Biomea Fusion and raising the price target from $40 to $45 is positive for the stock. This indicates that the analyst has a bullish outlook on the company's performance and expects the stock price to rise in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100